Literature DB >> 4924107

Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice.

B M Greenwood, A Voller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4924107      PMCID： PMC1712870     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice.

Authors:  P J Russell; J D Hicks
Journal:  Lancet       Date:  1968-03-02       Impact factor: 79.321

2.  Rodent plasmodia of the République Centrafricaine: the sporogony and tissue stages of Plasmodium chabaudi and P. berghei yoelii.

Authors:  I Landau; R Killick-Kendrick
Journal:  Trans R Soc Trop Med Hyg       Date:  1966       Impact factor: 2.184

3.  Statolon in murine autoimmune disease.

Authors:  A S Russell
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

4.  Autoimmune disease and parasitic infections in Nigerians.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

Review 5.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

6.  Elution of antinuclear factor from renal lesions of NZB-NZW mice.

Authors:  A R McGiven; P N Ironside
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

7.  Interferon induced by Plasmodium berghei.

Authors:  K Y Huang; W W Schultz; F B Gordon
Journal:  Science       Date:  1968-10-04       Impact factor: 47.728

8.  Particles resembling murine leukaemia virus in New Zealand black mice.

Authors:  P R Prosser
Journal:  Clin Exp Immunol       Date:  1968-03       Impact factor: 4.330

9.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307
View more
  13 in total

1.  Rheumatology in the Third World.

Authors:  A O Adebajo
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

2.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

3.  The effect of malaria on the relative affinity of mouse antiprotein antibody.

Authors:  M W Steward; A Voller
Journal:  Br J Exp Pathol       Date:  1973-04

4.  Immunosuppression in murine malaria. I. General characteristics.

Authors:  B M Greenwood; J H Playfair; G Torrigiani
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

5.  The pathogenesis of autoimmunity in New Zealand mice. IV. Independent stimulation of antibodies to DNA and RNA.

Authors:  D E Powell; A D Steinberg
Journal:  Clin Exp Immunol       Date:  1972-11       Impact factor: 4.330

6.  Mysteries of kidney-protecting parasitic infection revealed.

Authors:  Joanna Clarke
Journal:  Nat Rev Rheumatol       Date:  2021-08       Impact factor: 20.543

7.  Autoantibodies in sera of Thai patients with Plasmodium falciparum infection.

Authors:  S Boonpucknavig; G Ekapanyakul
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. II. NZB mice.

Authors:  B M Greenwood; A Voller
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

9.  Characterization and pathological significance of monoclonal DNA-binding antibodies from mice with experimental malaria infection.

Authors:  C M Lloyd; I Collins; A J Belcher; N Manuelpillai; A O Wozencraft; N A Staines
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  The absence of antibodies to malaria and human immunodeficiency virus, and the presence of hepatitis B surface antigen as diagnostic markers of rheumatoid arthritis.

Authors:  A O Adebajo; B L Hazleman
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.